Results 181 to 190 of about 16,768,241 (334)

Long COVID, invisible illness

open access: yes
Executive Summary Design and Multidisciplinary Framework This self-initiated, independently funded research program, originating in general and family practice, adopts a multidisciplinary framework by engaging patients as active partners throughout ...
Reseau de Recherche Long Covid,   +1 more
core  

Cholesterol Laundry of Cell Membrane and Fatty Liver by Detergent Liposomes to Improve Anti‐Cancer Drug Responsiveness of Patient Liver Tissues

open access: yesAdvanced Science, EarlyView.
Cholesterol‐enriched plasma membranes in hepatocellular carcinoma impede drug penetration. Cholesterol (+)‐liposomes act as membrane‐specific detergents, extracting cholesterol and reducing barrier function without cytotoxicity. Following endocytosis, cholesterol transfers from endosomes to liposomes and is metabolized in the ER.
Chansik Kim   +9 more
wiley   +1 more source

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches

open access: yesFrontiers in Immunology
The coronavirus disease 2019 (COVID-19) pandemic caused by SARS-CoV-2 has been defined as the greatest global health and socioeconomic crisis of modern times. While most people recover after being infected with the virus, a significant proportion of them
R. Gheorghita   +8 more
semanticscholar   +1 more source

Nanomaterials for Allergy Diagnosis and Treatment: Advances, Opportunities and Translational Challenges

open access: yesAdvanced Science, EarlyView.
Nanomaterials offer dual applications in allergy management. For diagnosis, nanomaterials enhance analytical sensitivity and improve detection in specific IgE and functional assays such as the basophil activation test (BAT). For allergen‐specific immunotherapy, nanomaterials enable allergen masking and controlled release, and effectively modulate the ...
Madiha Habib   +8 more
wiley   +1 more source

Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology

open access: yesMedical Review
Long COVID, as currently defined by the World Health Organization (WHO) and other authorities, is a symptomatic condition that has been shown to affect an estimated 10 %–30 % of non-hospitalized patients after one infection.
A. Ewing   +6 more
semanticscholar   +1 more source

The Long COVID Conundrum [PDF]

open access: yesThe American Journal of Medicine, 2022
openaire   +2 more sources

Real‐Time and Non‐Invasive Detection of Respiratory Viral Infections Using an Intelligent Odor Monitoring System (IOMS)

open access: yesAdvanced Science, EarlyView.
An intelligent odor monitoring system integrates an IVC animal model, gas sensor array, real‐time resistance readout, and machine‐learning analysis to continuously monitor infection‐associated odor changes. The platform captures longitudinal sensor responses, distinguishes infected from healthy states, and supports early‐stage respiratory viral ...
Yajie Shen   +17 more
wiley   +1 more source

Dynamics of post-COVID asthenia: review

open access: yesСибирский научный медицинский журнал
Novel coronavirus infection (COVID-19) is a highly contagious respiratory disease caused by the SARS-CoV-2 coronavirus. COVID-19 is known to affect both the respiratory, digestive, excretory, and nervous systems.
A. V. Ageykin   +9 more
doaj   +1 more source

Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID

open access: yesMedical Review
COVID-19 posed a major challenge to the healthcare system and resources worldwide. The popularization of vaccines and the adoption of numerous prevention and control measures enabled the gradual end of the COVID-19 pandemic.
Ming Guo   +6 more
semanticscholar   +1 more source

I Congreso Iberoamericano Long COVID y su impacto sobre las enfermedades crónicas (16 - 18 de marzo de 2023)

open access: yes, 2023
El COVID nos ha llevado, en muchos casos, a replantear la medicina. Debido a este virus sobrepasamos nuestros recursos y capacidades de aprendizaje, porque presentó una patología diferente.
Congreso Iberoamericano Long COVID (1° : 2023 : Lima)
core  

Home - About - Disclaimer - Privacy